NCT00762866
Psychiatric Genotype/Phenotype Project Repository
Enrolling by Invitation
Not specifiedAges 16–65ObservationalVanderbilt UniversityInvestigator-initiated
~2,000 participants
Updated 2026-01-27 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Brain volume
Measured over 2 years
Conditions
Where it's being run
1 sites across 1 statesTennessee1
Study leadership
- Stephan Heckers, M.D. · PRINCIPAL_INVESTIGATOR · Vanderbilt University
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Unipolar Major Depressive Disorder of any subtype
Bipolar I, Bipolar II Disorder, or Bipolar Disorder NOS
Axis I Psychotic Disorder, which can include the diagnoses of Schizophrenia, Schizoaffective Disorder, Major Depression or Mania with Psychotic Features, Schizophreniform Disorder, Brief Psychotic Episode, or Psychotic Disorder NOS
Normal volunteer controls, individuals with no personal history of any Axis I disorder.
Exclusion
uncontrolled diabetes, hypothyroidism, Cushing's disease, or other significant endocrine condition (treated endocrine condition is allowed)
demyelinating disease
HIV infection
active hepatitis
CNS infection
clinically significant and unstable cardiovascular disease
any cancer involving the CNS (including metastatic disease)
What this trial measures
- Brain volume2 years
Observational neuromaging study